180 Life Sciences Corp (ATNF)
1.42
+0.04
(+2.90%)
USD |
NASDAQ |
Oct 04, 16:00
1.46
+0.04
(+2.82%)
After-Hours: 20:00
180 Life Sciences Shareholders Equity (Annual): -0.1277M for Dec. 31, 2023
Shareholders Equity (Annual) Chart
Historical Shareholders Equity (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | -0.1277M |
| December 31, 2022 | 11.34M |
| December 31, 2021 | 39.32M |
| Date | Value |
|---|---|
| December 31, 2020 | 30.29M |
| December 31, 2019 | 38.57M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Annual) Range, Past 5 Years
-0.1277M
Minimum
2023
39.32M
Maximum
2021
23.88M
Average
30.29M
Median
2020
Shareholders Equity (Annual) Benchmarks
| Seelos Therapeutics Inc | -33.51M |
| NovaBay Pharmaceuticals Inc | 3.314M |
| Palatin Technologies Inc | -0.1115M |
| iBio Inc | 21.32M |
| Theriva Biologics Inc | 39.70M |